Advertisement
News
Advertisement

Merck acquires diabetes drug firm SmartCells

Thu, 12/02/2010 - 5:36am
Mass High Tech: The Journal of New England Technology

SmartCells Inc., a Beverly diabetes drug developer, is to be acquired by Merck & Co. Inc. for a total of about $500 million, according to a news release today.

The transaction will bring SmartCells’ outstanding stock to Merck, while SmartCell shareholders will be given an upfront cash payment, plus potential development and regulatory milestone payments.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading